Abselion has expanded its Amperia™ platform with a Tagged Protein Quantification Kit | His-tag and a Tagged Protein Sensor | ...
CAMBRIDGE, England--(BUSINESS WIRE)--Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, has expanded its Amperia™ assay portfolio with the ...
Despite major advances in LC-MS, achieving consistent protein quantification remains challenging in early drug discovery. Complex matrices and limited sensitivity often hinder reliable biomarker ...
The company highlights how its technology powers large-scale proteomic perturbation studies, unveiling Perturb-PBMC, a 1.4 million–protein PBMC dataset available in the Nomic Portal Nomic Bio (“Nomic” ...
As gene therapies continue to advance, the demand for scalable, reproducible, and efficient potency assays is rapidly increasing—especially for adeno-associated virus (AAV) vectors. Accurate ...
Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, today announced the launch of its Protein G Total Antibody Quantification Kit. The new kit is ...
When confirming antibody concentrations, sizing up proteins, or seeking the perfect formulation for a next-gen biologic, traditional approaches leave researchers tied to the lab bench for way too long ...
This webinar explores how real-time, in-line process monitoring delivers actionable, non-destructive insight across ...
Ready-to-use solution, developed in collaboration with GenScript, offers rapid and reliable quantification of His-tagged proteins Broadens Amperia’s applications across recombinant protein research, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results